Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NVIDIA
NVDA
5
Broadcom
AVGO
US Stock MarketDetailed Quotes
AbCellera Biologics (ABCL)
- 4.180
- -0.110-2.56%
Close Jan 15 16:00 ET
- 4.190
- +0.010+0.24%
Post 19:59 ET
1.25BMarket Cap-7.33P/E (TTM)
4.335High4.080Low5.32MVolume4.335Open4.290Prev Close22.30MTurnover2.60%Turnover RatioLossP/E (Static)299.34MShares6.51552wk High1.30P/B854.08MFloat Cap1.89152wk Low--Dividend TTM204.32MShs Float71.910Historical High--Div Yield TTM5.94%Range %1.891Historical Low4.192Avg Price1Lot Size
AbCellera Biologics (ABCL) Key Financial Indicators
ABCL Earnings per Share (EPS)
According to the latest financial report of AbCellera Biologics, the latest earnings per share (TTM) for the company is -0.19. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ABCL Free Cash Flow (FCF)
Interested in knowing about AbCellera Biologics's free cash flow? The latest report shows it as -61.52M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ABCL Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of AbCellera Biologics shows that the company's current ratio is 10.10, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ABCL Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of AbCellera Biologics, the quick ratio is 9.52, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ABCL Return on Equity (ROE)
Want to learn more about the financial health of AbCellera Biologics? The latest ROE figure is -5.80%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ABCL Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of AbCellera Biologics, the total asset return on investment (ROA) is -4.14%.
Currency: USD
Quarterly
Loading...
ABCL Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check AbCellera Biologics's latest financial report to see how their gross margin is doing - currently at 92.79%.
Currency: USD
Quarterly
Loading...
ABCL Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of AbCellera Biologics, the net profit margin is -637.84%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?